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Hypotension and Hypocapnia During General Anesthesia
in Piglets: Study of S100b as an Acute Biomarker for
Cerebral Tissue Injury
Nicola G. Clausen, MD, PhD,*†‡ Steen Antonsen, MD, PhD,§ Nelly Spielmann, MSc,†‡
Tom G. Hansen, MD, PhD,* Markus Weiss, MD, DMSc,†‡ and Simone K. Ringer, DVM, PhD∥
Background: Hypotension and/or hypocapnia might increase general
anesthesia (GA)-related neuromorbidity in infants, but safe levels of
perioperative blood pressure are poorly defined. Serum protein S100b
has been used as screening, monitoring, and prediction tool in the
management of patients with traumatic brain injury. Using an animal
model, we investigated serum S100b as an acute biomarker of cerebral
hypoperfusion and cerebral cell dysfunction during hypotension, hy-
pocapnia, or combined hypotension/hypocapnia during GA.
Methods: Fifty-seven sevoflurane-midazolam anesthetized piglets
aged 4 to 6 weeks were randomly allocated to control (n=9), hypo-
tension (n=18), hypocapnia (n=20), or combined hypotension and
hypocapnia (n=10). Hypotension (target mean arterial blood pres-
sure: 35 to 38 or 27 to 30mmHg) was induced by blood withdrawal
and nitroprusside infusion, and hypocapnia by hyperventilation (target
PaCO2: 28 to 30 and 23 to 25mmHg). Serum S100b and albumin
were measured at baseline, before and 60 minutes after the inter-
ventions, and following 60-minute recovery.
Results: Serum S100b concentrations decreased over time (P=0.001),
but there was no difference in S100b between control piglets and those
exposed to hypotension, hypocapnea, or a combination of the both
(P=0.105). Albumin decreased in all 4 groups (P=0.001).
Conclusion: S100b did not increase following 60 minutes of systemic
hypotension and/or hypocapnia during GA in piglets. In this setting,
the use of S100b as a biomarker of cerebral cell tissue dysfunction
cannot be supported.
Key Words: anesthesia, general, cerebral circulation, vascular
hypotension, domestic pig, biologic marker, S100 calcium bind-
ing protein beta subunit
(J Neurosurg Anesthesiol 2019;00:000–000)
The risks associated with general anesthesia (GA) inchildren are increasingly acknowledged. Recently, the
APRICOT study reported a 5.2% incidence of critical
adverse events in pediatric anesthesia practice in Europe.1
Fifty-five percent of the cardiovascular adverse events
reported in this study were arterial hypotension. Peri-
anesthetic arterial hypotension has previously been found to be
associated with decreased regional cerebral oxygen saturation
measured by near-infrared spectroscopy.2 In a preclinical
model, our group recently showed that cerebral tissue partial
pressure of oxygen decreased significantly when blood pressure
was lowered to 27 to 30 or 35 to 38mmHg.3 In a clinical
pediatric setting, however, there are currently no reliable means
to estimate neuronal injury during GA. Glial protein S100b is
clinically used as a biomarker for characterizing mild traumatic
brain injury4 and has been associated with perioperative neu-
romorbidity in neonates undergoing cardiac surgery.5
We hypothesized that systemic hypotension and
hypocapnia in piglets, either alone or in combination,
would reduce cerebral perfusion and may cause neuronal
cell damage which might be reflected in an increase in
serum levels of S100b. The aim of this study was to assess
any association between cerebral hypoperfusion during
GA and serum levels of S100b. In a pediatric piglet model,
we compared serum levels of S100b and albumin (to es-
timate hemodilution) during stable GA and GA with
temporary hypotension, hypocapnia or combined hypo-
tension, and hypocapnia.
METHODS
The study was approved by the local Ethics Committee
for Animal Experiments (License number ZH175/16). We
chose 4- to 6-week-old piglets to test our hypothesis because,
at that age, the pig brain is similar to infants in morphology
and development.6
Fifty-seven, 4- to 6-week-old piglets (breed: pure large-
white, Swiss landrace or duroc, or crossings of the 3) were
included in the study. The piglets were housed in their home
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facility until transportation in boxes padded with straw and
side openings for ventilation. The piglets were randomly allo-
cated to 1 of 4 groups: control (C) (n=9), moderate or severe
hypotension (HT) (n=18), moderate or severe hypocapnia
(HC) (n=20), or moderate hypotension and hypocapnia
combined (HTC) (n=10). All animals were anesthetized ac-
cording to an identical protocol (see below). A supplement
outlining the study compliance with the Animal Research:
Reporting in Vivo Experiments guidelines is provided in the
supplementary material (Supplemental Digital Content 1,
http://links.lww.com/JNA/A116).7
Anesthesia and Instrumentation
This study was part of our aforementioned study, and
the experimental protocol is described in detail elsewhere.3 In
brief, after mask induction of anesthesia with sevoflurane in
oxygen, the animals were continuously monitored with pulse
oximetry, expired gases, including end-tidal carbon dioxide
(EtCO2), spirometry, electrocardiogram, rectal temperature,
and invasive blood pressure by a 22-G catheter (BD Insyte-A,
VD Vialon Material; Becton Dickinson, Allschwil, BL, Swit-
zerland) inserted into the femoral artery. Two intravenous (IV)
catheters were placed in ear veins. Without administration of a
muscle relaxant, the animals were orotracheally intubated with
a cuffed tube size 4.0 (Microcuff; Kimberly-Clark GmbH,
Niederbipp, Switzerland) while placed in the sternal position.
The animals were mechanically ventilated (Avance CS2;
Anandic Medical Systems AG, Feuerthalen, Switzerland)
throughout the experiment. Anesthesia was maintained with
sevoflurane in oxygen/air mixture and a continuous infusion of
midazolam (1mg/kg/h). After administration of an IV bolus of
fentanyl (10 µg/kg) and local infiltration with lidocaine 0.1mL
and bupivacaine 0.1mL, the piglets were instrumented with
frontal craniotomy bolts to allow monitoring of cerebral tissue
partial pressure of oxygen and cerebral blood flow. A single
operator (N.G.C.) performed these procedures. Data from
these intracranial monitoring devices were included in our
previously published study3 and are not relevant to the current
study.
An experienced veterinarian anesthetist (S.K.R.) con-
tinuously assessed the animals. Normoxia, normocapnia, nor-
moglycemia, and normothermia were maintained and the
piglets were hydrated with an IV infusion of Ringer’s acetate
with glucose 1% (5mL/kg/h). Unintended arterial hypotension
(mean arterial blood pressure [MAP] <50mmHg) was treated
with a norepinephrine infusion starting at 0.03 µg/kg/min and
titrated according to effect.
Study Protocol
Two hours after instrumentation, stable physiological
parameters were confirmed and the experimental protocol was
initiated. In the HT group, hypotension was induced by
withdrawal of arterial blood (10mL/kg body weight over 5
min) and nitroprusside infusion (starting dose 6 µg/kg/min,
titrated to effect). In animals randomized to the HT group,
norepinephrine infusion was discontinued if it had previously
been started to maintain MAP. Target MAP values in the HT
group were 35 to 38mmHg for moderate hypotension and 27
to 30mmHg for severe hypotension. Once the target MAP
had been reached, blood pressure and anesthesia were main-
tained stable for 60 minutes. Subsequently, normotension was
restored by the discontinuation of nitroprusside infusion and
restoration of the volume of blood withdrawn with balanced
hydroxyethyl starch 130/0.4. In the HC group, hypocapnia was
induced by increasing the ventilation rate and tidal volume.
Target PaCO2 values were 28 to 30 and 23 to 25mmHg for
moderate and severe hypocapnia, respectively. In piglets allo-
cated to the HTC group, moderate hypotension and hypo-
capnia were induced simultaneously using the protocols
described previously. Each intervention was followed by a
60-minute recovery period with stable vital parameters within
normal ranges. Anesthesia in control animals was kept stable
for identical timeframes. After final blood sampling, including
arterial blood gases, the piglets were euthanized with T61 eu-
thanasia solution.
Blood Sampling and Analyses
Venous and arterial blood samples were collected for
measurement of S100b and albumin (to estimate hemodilution)
at the following timepoints: after induction of anesthesia and
instrumentation (baseline [B]), at the start [Tr0], and end of the
treatment intervention [Tr60] (i.e., HT, HC, or HTC), and after
60 minutes of recovery with normal vital signs [post-Tr60]
(Fig. 1). The samples were left to clot for 60 minutes,
centrifuged at 1400g for 7 minutes, frozen and subsequently
stored at −80°C until analysis. On the day of analysis, the
samples were thawed, centrifuged, and the tests performed on
the supernatants. All 4 samples from the same animal were
analyzed on the same day, and venous samples were preferred.
If ≥1 venous sample was missing, then arterial samples were
used for all measurement points in that animal.
S100b and albumin were measured on the same
blood sample. S100b was measured by chemiluminescence
immunoassay (Cobas e602; Roche Diagnostics, Roche a/s,
Hvidovre-Copenhagen, Denmark). Albumin was analyzed
by colorimetry using bromocresolgreen (Cobas c702;
Roche Diagnostics). The intra-assay and interassay co-
efficients of variability of samples from the piglets were
2.1% and 1.4%, respectively, for S100b and 3.9% and
1.3%, respectively, for albumin.
Statistical Analysis
Data were analyzed at baseline (B), at the start of
treatment (Tr0), after 60 minutes of treatment (Tr60), and after
60 minutes of recovery (post-Tr60) using IBM SPSS Statistics
Version 22 (IBM Corp) and GraphPad Prism 5 for Mac OS X
software. Kolmogorov-Smirnov and Saphiro-Wilk were used
to test for normality distribution. Repeated measures mixed
ANOVA followed by Sidak and Bonferroni post hoc tests were
used to investigate changes over time and between groups. All
data are presented as mean±SD. A P-value <0.05 was con-
sidered statistically significant.
RESULTS
All 57 piglets completed the study without any ad-
verse events, and the intended treatment interventions
were delivered in all animals. Demographics are presented
in Table 1. S100b and albumin at the various study
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timepoints (B, Tr0, Tr60, and post-Tr60) are shown in
Figure 2, and individual serum levels of S100b and albumin
(for control and treatment groups) in supplementary material
(Supplementary Figs. 2 and 3, Supplemental Digital Content
2, http://links.lww.com/JNA/A117 and Supplemental Digital
Content 3, http://links.lww.com/JNA/A118).
In all 4 groups, S100b concentrations decreased over
time (P= 0.001) independent of interventions (P= 0.105).
Similar changes were seen when arterial samples were
excluded from the analysis (data not shown). The S100b
pattern differed substantially in piglet number 13 (group HT):
S100b at baseline was 1.11 µg/L, peaked at Tr0 (3.99 µg/L), and
then decreased. Tr60 and post-Tr60 values remained com-
paratively high (3.26 and 2.93 µg/L, respectively). To avoid
inclusion of results based on erroneous measurements, the
samples of piglet 13 were retested and the results remained
unchanged. As piglet 13 and its anesthetic course did not differ
notably from the other animals, these data were included in the
statistical analysis.
S100b was primarily analyzed in venous blood
samples. However, in 5 piglets, venous blood could not be
withdrawn and arterial blood samples were used for
analysis. To check for differences in S100b levels accord-
ing to blood specimen type, we measured S100b in both
arterial and venous blood samples in 3 random piglets.
The mean difference was 14% with arterial S100b lower
than venous. Therefore, inferential statistics were repeated
excluding data from the 5 piglets in whom venous blood
could not be withdrawn (n= 1 group C, n= 1 group HC,
and n= 3 group HT). Overall, the results were unchanged.
TABLE 1. Demographics and Study Characteristics
Overall Controls Hypotension Hypocapnia Hypocapnia+Hypotension
No. piglets 57 9 18 20 10
Mean age±SD (d) 33.5± 5.9 30.8± 6.7 34.9± 5.7 33.3± 5.4 34.1± 5.5
Mean weight ± SD (kg) 6.6 ± 0.7 6.6± 0.8 6.5± 0.7 6.4 ± 0.7 6.9 ± 0.7
Norepinephrine infusion at baseline (%) 50.9 77.8 55.6 45.0 30.0
Norepinephrine infusion after treatment (%) 66.7 77.8 66.7 70.0 50.0
Anesthesia time (mean±SD) (min)* 220.5± 35.7 211.9± 37.8 236.1± 44.3 210.9± 26.0 219.6± 20.2
Anesthesia time total (mean±SD) (min)† 343.7± 37.9 338.8± 33.6 360.9± 51.1 333.9± 24.6 337.0± 22.0
Columns: study characteristics for total study population and per study group.
Rows: number of piglets; piglets mean age ± SD; piglets mean weight ± SD; proportion of piglets (in percent) requiring infusion of norepinephrine to maintain mean
arterial pressure of ≥ 50mmHg at timepoints baseline and Tr60; mean duration of anesthesia in minutes from time of induction to start of treatment (Tr0) ± SD (variations
because of different length of time used for instrumentation and adjustment to target mean arterial pressure according to the allocated treatment group); mean duration of
anesthesia in minutes from time of induction to end of recovery (post-Tr60).
*Induction of anesthesia to start of treatment (Tr0).
†Induction of anesthesia to end of recovery (post-Tr60).
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Only at timepoint post-Tr60, did S100b differ significantly
between the combined HTC group and piglets treated with
HC alone (Pincluding_art= 0.038, Pexcluding_art= 0.65). The
actual S100b differences, however, were minor (mean±
SD, 0.327± 0.091 in group HTC and 0.416± 0.128 in
group HC), and unlikely to be of clinical relevance.
Albumin decreased from baseline to post-Tr60 in-
dependent of intervention (P= 0.001). However, some
statistical differences were detected between treatment
groups: at timepoints Tr60 and post-Tr60, albumin was
lower in the group HTC compared with controls
(P= 0.001). Further, albumin in the group HTC differed
significantly from that in the group HC at the end of recovery
(P=0.038). However, after exclusion of arterial samples, this
difference was no longer significant (P=0.65).
DISCUSSION
In piglets, neither GA with sevoflurane and midazolam
nor hypotension and/or hypocapnia triggered an increase in
serum S100b. From induction of anesthesia onwards, S100b
decreased in all piglets irrespective of treatment, including in
the control animals. Adjusting S100b results for dilution by
comparison with relative changes in albumin did not change
this pattern (data not shown).
Ringer et al8 exposed piglets to hypotension or hy-
pocapnia during sevoflurane anesthesia and demonstrated
signs of neuronal dysfunction and early ischemia on
magnetic resonance imaging. As an extension of this
model, we investigated the association between periodic
hypotension and brain tissue oxygen partial pressure, re-
gional cerebral oxygen saturation, or cerebral blood flow
in a previous study.3 Although no changes in brain tissue
oxygen partial pressure were detected over time in the
control group, a significant decrease in partial pressure
was observed immediately after the induction of hypo-
tension. In addition, base excess was reduced (mean±SD at
baseline, 4.8±1.85 vs. 2.0±2.65mmol/L at Tr60) and serum
lactate increased (mean±SD, 1.5±0.42 vs. 2.4±0.9mmol/
L) suggesting severe systemic hypoperfusion.
In an adult pig model, linear changes between EtCO2
and brain tissue oxygen partial pressure were shown within
the range of 20 to 60mmHg.9 Similarly, brain tissue oxy-
gen partial pressure was reduced by 17% and 57%, re-
spectively, following moderate (EtCO2 30mmHg/4.0 kPa)
and severe (EtCO2 20mmHg/2.7 kPa) hyperventilation.
10
These results indicate that perianesthetic hypotension and/
or hypocapnia reduce cerebral oxygenation.
In the normal developing brain, and following acute
glial activation in response to injury, extracellular S100b
has beneficial trophic activities and acts as a neuronal
survival protein.11 In contrast, S100b at high concen-
trations is known to be directly neurotoxic and associated
with poor prognosis of chronic neuroinflammatory
diseases.12 A decrease in S100b as detected in our experi-
ment might be explained by dysfunction of a glial acti-
vation cycle.12
Besides reflecting injury to neuroglia, S100b has
been suggested as a marker of blood-brain barrier (BBB)
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FIGURE 2. Repeated measures of S100b and albumin at timepoints baseline (B), treatment start (Tr0), treatment end (Tr60), and
end of recovery (post-Tr60). Serum levels shown for controls and treatment groups. S100b is presented as µg/L and albumin as g/L.
C indicates control; HC, hypocapnia; HT, hypotension; HTC, hypotension/hypocapnia groups.
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integrity.13 S100b is hydrophilic and does not easily pen-
etrate the tight junctions of the BBB. Using a model
identical to ours, Ringer et al8 were able to demonstrate
signs of neuronal dysfunction and ischemia. Thus, we as-
sume that the injury they identified would be similar to that
in the current study. However, the impact of the inter-
ventions in our study might have been too small to allow
for any systemic leakage of intracerebral S100b through the
BBB. This somewhat contradicts the fact that S100b can be
elevated even in mild head trauma with discrete clinical
symptoms (Glasgow Coma Score 14 or 15).14
Recent research suggests that S100b does not leak
from cerebrospinal fluid to serum through breaches in the
BBB. Rather, it is released from astrocytes through
aquaporin-4 receptors into the Virchow-Robin space, a
pia-lined interstitial fluid-filled space in the brain that
surrounds vessels perforating deep into the brain white
matter. Metabolites from neurons and glia cells are
cleared from this space by “convective glymphatic flow”
and drained to the venous circulation through the cervical
lymph nodes.15,16 The flow through the glymphatic system
is driven by arterial pulsation. The fluid volume in the
cerebral perivascular space increases during sleep and GA
but decreases in the awake state. This could explain why
S100b levels in serum decreased at all timepoints in-
dependent of treatment group in our study—even in the
control group, where cerebral perfusion would not be
expected to be compromised. Several studies have re-
ported neuroprotective effects of inhalational anesthetics
in both in vitro and preclinical models.17,18 It could be
speculated that this compensation is because of increased
glymphatic flow rather than an effect of the anesthetic
per se. Either way, sevoflurane may compensate for a
damaging effect caused by hypotension and/or hypo-
capnia.
S100b is clinically used as a biomarker to categorize
the severity of adult traumatic brain injury.4 In a recent
update of the Scandinavian guidelines for initial manage-
ment of adult patients with minimal, mild, and moderate
head trauma, S100b was added as a clinical tool14: the bio-
marker, when sampled within 6 hours of the incident, can
guide clinicians to decide between immediate computed
tomography scan and/or observation under admission or
discharge.14 Its prognostic value in neonatal and pediatric
brain-injured populations is also under investigation.19
S100b has been studied as an early biomarker of perioper-
ative brain injury. In 18 neonates undergoing early surgery
for congenital heart disease on cardiopulmonary bypass,
S100b increased during surgery and returned to baseline
values postoperatively.5 Further, increased levels of S100b
up to 48 hours after procedures have been associated with
impaired neurodevelopment at 2 years of age.20 However,
extracerebral contamination of S100b originating from me-
diastinal fat tissue or shed blood21 has been postulated to
minimize the utility of S100b as a perioperative injury
marker in this population.22
Neonatologists have investigated the prognostic
value of S100b to predict neuromorbidity in neonates with
hypoxic-ischemic encephalopathy (HIE). Compared with
healthy controls, neonates with HIE expressed higher
levels of S100b in umbilical cord blood within a few hours
after birth. Furthermore, S100b correlates positively with
the severity of HIE and the risk of permanent sequelae,23
and is increased in preterm infants who subsequently de-
velop intraventricular hemorrhage.19 Asphyxiated infants
with impaired neurodevelopment at 12-month follow-up
have increased urine S100b levels during the first 72 hours
of life.24 However, measurement of S100b has not yet been
implemented as standard monitoring in at-risk neonates.
In the present study, mean baseline levels of S100b
were higher in group C (0.94 ± 0.38 mmol/L) than in the
intervention groups (HT, 0.67 ± 0.25 mmol/L; HC,
0.55 ± 0.2 mmol/L; HTC, 0.62 ± 0.29 mmol/L). This dif-
ference might be spurious and related to the low number
of piglets (n= 9) in group C. Two of them showed com-
paratively high baseline levels of S100b (1.45 and 1.52
mmol/L), and mean levels excluding these 2 piglets
(0.78 ± 0.22 mmol/L) approximated to the S100b levels of
the other groups. There was a decrease in serum albumin
at Tr60 and post-Tr60 in the hypotensive groups, and this
was likely because of hemodilution following replacement
of withdrawn blood with Voluven to re-establish normo-
volemia.
The following should be considered when interpreting
the results of the current study. Analysis of pig serum with a
human S100b assay might have influenced the results. How-
ever, human S100b assays have previously been used in pigs,25
and are considered feasible because S100b is highly conserved
among various animal species.26 Our study was performed
over a period of 4 months and the serum analyses were per-
formed following the inclusion of all animals. However,
S100b concentrations have been found to be unaffected by
storage time, so this is unlikely to have influenced our
results.27 Further, S100b is not sensitive to hemolysis.11 In
addition, samples were centrifuged onsite after being collected
and frozen immediately. This minimized the risk of any fur-
ther decay.27 Interventions and recovery were maintained for
60 minutes and the mean total duration of anesthesia ranged
between 333 minutes (group HC) and 360 minutes (group
HT). The elimination half-time of S100b ranges from 25 mi-
nutes28 to 200 minutes.29 As S100b is measurable in serum,
20 minutes following an insult,29 the timeframe used in the
current study should be adequate to detect any change. Only
piglets previously unexposed to GA were included. Male
piglets are exposed to GA for castration at the age of 3 weeks,
so only female piglets were used in the present study. This
may be important and could have influenced our results; fe-
male piglets may respond differently to brain injury induced
by hemorrhagic shock, with a reduced release of S100b
compared with male animals.30 A piglet model was chosen
because there is a good resemblance between the morpologic
and neurophysiological development of the swine and human
brain.6 However, piglets require higher doses of anesthetics to
reach a sufficient depth of anesthesia compared with human
infants. Hence midazolam infusion was added to ensure that
the piglets had low muscle tone, did not shiver or breathe
spontaneously. This does not reflect clinical practice and may
limit the translational value of our results.
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CONCLUSION
In piglets exposed to stable GA maintained with
sevoflurane and midazolam, serum levels of S100b steadily
decreased over time. Hypotension, hypocapnia, or a
combination of the 2 did not affect serum S100b levels;
whether any S100b was released into cerebrospinal fluid is
unknown. Consequently, this study does not support the
hypothesis that S100b can be used as a biomarker of
cerebral cell dysfunction in piglets under GA.
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